Elena Giardino

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Expression of Concern: Specific roles of Gi protein family members revealed by dissecting SST5 coupling in human pituitary cells.

Expression of Concern: Specific roles of Gi protein family members revealed by dissecting SST5 coupling in human pituitary cells.

Journal: Journal of cell science
Published: November 28, 2022

Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells.

Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells.

Journal: Molecular and cellular endocrinology
Published: July 28, 2020

Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion.

Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion.

Journal: Molecular and cellular endocrinology
Published: June 09, 2020

The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells.

The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells.

Journal: Cancer letters
Published: May 28, 2020

Beta-Arrestin 2 Is Required for Dopamine Receptor Type 2 Inhibitory Effects on AKT Phosphorylation and Cell Proliferation in Pituitary Tumors.

Beta-Arrestin 2 Is Required for Dopamine Receptor Type 2 Inhibitory Effects on AKT Phosphorylation and Cell Proliferation in Pituitary Tumors.

Journal: Neuroendocrinology
Published: November 06, 2019

Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior.

Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior.

Journal: Frontiers in endocrinology
Published: July 30, 2019

Cytoskeleton Protein Filamin A Is Required for Efficient Somatostatin Receptor Type 2 Internalization and Recycling through Rab5 and Rab4 Sorting Endosomes in Tumor Somatotroph Cells.

Cytoskeleton Protein Filamin A Is Required for Efficient Somatostatin Receptor Type 2 Internalization and Recycling through Rab5 and Rab4 Sorting Endosomes in Tumor Somatotroph Cells.

Journal: Neuroendocrinology
Published: May 10, 2019

Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation.

Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation.

Journal: Molecular and cellular endocrinology
Published: February 06, 2019

Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors.

Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors.

Journal: Endocrine-related cancer
Published: November 14, 2018

Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activity.

Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activity.

Journal: Molecular and cellular endocrinology
Published: June 26, 2018

cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells.

cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells.

Journal: Cancer letters
Published: May 10, 2018

Single-Molecule Microscopy Reveals Dynamic FLNA Interactions Governing SSTR2 Clustering and Internalization.

Single-Molecule Microscopy Reveals Dynamic FLNA Interactions Governing SSTR2 Clustering and Internalization.

Journal: Endocrinology
Published: April 19, 2018
Showing 1-12 of 23

Last Updated: 09/26/2026